About 127 Trademarks found that are owned by Novo Nordisk Health Care Ag

Pharmaceutical preparations for the treatment of hematological conditions, pharmaceutical preparations for the treatment of anemia, pharmaceutical preparations for the treatment of sickle cell disease.

Pharmaceutical preparations for the treatment of hematological conditions, pharmaceutical preparations for the treatment of anemia, pharmaceutical preparations for the treatment of sickle cell disease

Pharmaceutical preparations for the treatment of hematological conditions, pharmaceutical preparations for the treatment of anemia, pharmaceutical preparations for the treatment of sickle cell disease.

Pharmaceutical preparations for the treatment of hematological conditions, pharmaceutical preparations for the treatment of anemia, pharmaceutical preparations for the treatment of sickle cell disease.

Pharmaceutical preparations for the treatment of hematological conditions, pharmaceutical preparations for the treatment of anemia, pharmaceutical preparations for the treatment of sickle cell disease

Pharmaceutical preparations for the treatment of hematological conditions, pharmaceutical preparations for the treatment of anemia, pharmaceutical preparations for the treatment of sickle cell disease

Pharmaceutical preparations for the treatment of hematological conditions, pharmaceutical preparation for the treatment of anemia, pharmaceutical preparations for the treatment of sickle cell disease.

Pharmaceutical preparations for the treatment of hematological conditions, pharmaceutical preparations for the treatment of anemia, pharmaceutical preparations for the treatment of sickle cell disease

Providing healthcare information on hemophilia management and providing medical services for persons affected by hemophilia

Pharmaceutical preparations for the treatment of various diseases, namely, pharmaceutical preparations for the treatment of rare diseases in the nature of genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; drug delivery agents in the nature of oligonucleotide compounds for use in the targeted delivery of RNAi therapy; chemical compounds that act as a platform for the delivery of drugs in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Scientific research and development of pharmaceutical preparations, compounds for use in the targeted delivery of therapy, chemical compounds that act as a platform for the delivery of drugs, and drug delivery agents; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials